Navigation Links
Ampio Pharmaceuticals' Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
Date:9/8/2011

GREENWOOD VILLAGE, Colo., Sept. 8, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced a license and development agreement with Daewoong Pharmaceuticals Co. Ltd., providing Daewoong Co. Ltd. exclusive rights to market Zertane™ in South Korea for the treatment of premature ejaculation (PE) and for a combination drug, utilizing Zertane™ and another erectile dysfunction drug (PDE5 inhibitors and others), to simultaneously treat premature ejaculation and erectile dysfunction (ED).

About Daewoong Co. Ltd.

Daewoong is a leading pharmaceutical company in South Korea, ranking #1 in prescription drugs sold and #2 in manufacturing with more than $600 million in annual revenues and growing at an impressive rate over the last four years.  Daewoong was founded in 1945, trades on the South Korean stock exchange and employs over 1,400 people. Their success is the result of meticulous marketing research aimed at uncovering and adding products to their robust pipeline. They also have demonstrated an impressive ability to launch new products and execute on commercial strategies utilizing over 800 sales and marketing professionals.

Zertane™ Strategy

Don Wingerter, Ampio's CEO, noted : "Since our June 17, 2011 press release summarizing the positive clinical results of the two European Phase III trials of Zertane™, we have been contacted by numerous companies from all regions of the world seeking to license Zertane™.  As regulatory pathways and cultural attitudes vary from country to country, we have decided that optimizing Zertane™ sales around the world is best accomplished with country and region specific partners, each carefully chosen, and not w
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
2. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
3. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
4. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
5. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
6. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
7. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
8. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
9. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
10. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 ... of cartilage, cellular, bone, skin and soft-tissue allografts ... to advance patient healing, today announced that AlloWrap® ... been moved to the high-cost reimbursement category. ... reach doctors and their patients," said Kimberly ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the "United States ... report to their offering.      (Logo: ... adhesives in the United States ... 2020 Medical device manufacturers across ...
(Date:5/28/2015)... 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO ... Martell , to the position of Executive Chairman. Mr. ... Board of Directors. In this new role, he will ... refine and execute on the strategic plan to transition ... for orphan oncology indications with high unmet medical need. ...
Breaking Medicine Technology:AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5
... From today, an innovative non-drug, non-invasive treatment ... all hypertensive patients on NHS prescription. RESPeRATE is an ... When used for just 15 minutes a day, at ... significant, all-day blood pressure reduction beyond that seen with ...
... Therapeutics, Inc. (NASDAQ: HALO ) today presented ... tolerability study of HTI-501 (an investigational, conditionally active recombinant ... International Academy of Cosmetic Dermatology in Cancun, Mexico. Data ... portion of the clinical trial. The Phase 1/2 trial ...
Cached Medicine Technology:NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 2NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 3NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 4HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 2HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 3
(Date:5/28/2015)... 28, 2015 The Paw Project, ... a dramatic billboard intended to educate the Oregon public ... the busy intersection of Market Street and Park Avenue ... “If You’re for De-clawing Cats, Raise Your Hand,” depicts ... last joint, providing a graphic and anatomically-correct representation of ...
(Date:5/28/2015)... The CEO and Founder of Alliance ... blog series which provides analysis on the benefits of ... Bruce Dalglish” profile on Blogger.com, this instructive new series ... experience. , “Throughout my business career, I’ve witnessed ... the overall success of businesses,” stated R. Bruce Dalglish, ...
(Date:5/28/2015)... Dallas, TX (PRWEB) May 28, 2015 Ticket ... international friendly soccer match between Mexico and Argentina ... teams in the world will compete on the pitch at ... against one another in an international friendly on Tuesday, September ... the most talented nations in the world including some of ...
(Date:5/28/2015)... May 28, 2015 Real Time Pain ... and products, today announced their best-selling lotion is now available ... Pain Relief is an FDA registered OTC pain relief product. ... ingredients, such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu Oil, ... of Menthol – only 1.25% – to avoid buildup of ...
(Date:5/28/2015)... Norcross, GA (PRWEB) May 28, 2015 ... Huston, Inc. (BHI) , a provider of engineering, spatial ... to generate and analyze thousands of point clouds for ... , From 2012 to 2014, the BHI Spatial Data ... clouds from digital stereo aerial imagery. Collected by a ...
Breaking Medicine News(10 mins):Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3
... Brightens Queens Skyline, Sends Message About Heart HealthFLUSHING, N.Y., ... New York Hospital Queens:(Photo: http://www.newscom.com/cgi-bin/prnh/20090205/DC67402 ) Details: ... area will be wearing red on Friday, February 6, ... for Women" awareness campaign, the staff at one area ...
... and more take cues from hues, study finds, , , THURSDAY, ... red. Want to be more creative at work? Paint ... British Columbia analyzed the effect of color on 666 ... creative tasks presented on computer screens set to either a ...
... to educate retailers about the lawOLYMPIA, Wash., Feb. 5 ... has tripled since 2006, according to a new report. The ... 2008. That,s up from nine percent in 2007 and five ... ( www.doh.wa.gov ) is working with other state and local ...
... With focus on early detection of disease, A Su ... high cholesterol among participants and provided $55 million in ... Feb. 5 /PRNewswire/ -- ... its 2009 schedule of "A Su Salud" (To Your ...
... Texas M. D. Anderson Cancer Center have found that ... growth factor expression are associated with poor survival in ... presented in a poster session today at the Society ... , Sex cord-stromal ovarian tumors are rare, accounting ...
... Feb 5 Stephens Media LLC of,Las Vegas, ... of,Lisle, Illinois to deliver Surgery Benefit Management to ... quality surgical care and,personal savings through Healthplace America,s ... To date, the Healthplace,Surgery Benefit(TM) is the first ...
Cached Medicine News:Health News:It's a Wrap - New York Hospital Queens Goes Red Seven Stories Up to Build Awareness of Women's Risk for Heart Disease 2Health News:Color Can Affect How People Think and Act 2Health News:Color Can Affect How People Think and Act 3Health News:More Retailers Selling Tobacco to Minors 2Health News:More Retailers Selling Tobacco to Minors 3Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 2Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 3Health News:Angiogenesis linked to poor survival in patients with rare type of ovarian cancer 2Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 2Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 3Health News:Stephens Media LLC Partners With Healthplace America to Enhance Employee Healthcare Benefits With Quality and Savings for Surgery 4
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
The EnVision™ multilabel plate reader provides the speed you need, for example, in high throughput screening, together with the flexibility to accommodate the different kinds of assay that you ...
... The FLx800 is designed to combine excellent ... of use. This design incorporates powerful performance ... fluorescence microplate readers. The FLx800 line includes ... specific needs of research and OEM users, ...
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
Medicine Products: